Group 1 - The core point of the article is that Fuhuang Steel Structure plans to acquire Hefei Zhongke Junda Vision Technology Co., Ltd., marking its entry into the high-end precision scientific instrument sector [1] - Zhongke Vision possesses fully independent intellectual property rights for its "Thousand-Eye Wolf" high-speed camera and core products related to three-dimensional motion measurement, precision deformation morphology measurement, and dynamic fluid flow field measurement [1] - The company has accumulated 253 patents and its products are applied in research, aerospace, and high-end manufacturing, with exports to countries such as Germany, France, and Southeast Asia [1] Group 2 - The acquisition signifies a strategic diversification for Fuhuang Steel Structure into a market segment that currently lacks comparable listed companies in the A-share market [1] - This move highlights the company's ambition to expand its business portfolio and tap into the growing demand for high-end scientific instruments [1]

Core Insights - The article highlights the successful angel round financing of Lide Health Technology, raising nearly 100 million RMB, marking the largest angel financing in the life sciences and bio-manufacturing equipment sector in the past three years [2] - Lide Health, established in October 2023, focuses on AI and high-end life science instruments, aiming to provide microfluidic, automation, and intelligent system-level solutions for various fields [4] - The company has signed a cooperation agreement with Guangzhou Laboratory for the transformation of 22 patents, including several PCT international patents and invention patents, and has independently applied for 57 patents and 10 software copyrights [4] Company Overview - Lide Health is headquartered in Guangzhou International Biological Island and specializes in the research and development of high-end life science instruments and bio-manufacturing equipment [4] - The company has quickly achieved commercialization of technological achievements, signing commercial orders exceeding 10 million RMB with leading clients in 2024 [4] Core Technologies and Products - Lide Health's core technologies span microfluidic chips, life sciences, biopharmaceuticals, medical devices, robotic automation, and artificial intelligence [5] - The company has developed a series of proprietary products, including a single-cell multi-omics system and a high-throughput AI imaging flow cytometer, which are crucial for life science research and biopharmaceuticals [5][6] - The active single-cell sequencing system is a pioneering product in the industry, featuring active coding sorting technology and excellent sample compatibility [5] Upcoming Events - The article mentions several upcoming global medical technology conferences organized by Suyu, including the first Global Aesthetic Technology Conference on June 12, 2025, and the second Global Medical Technology Conference on July 17, 2025 [1][7]

Core Viewpoint - The article discusses the rapid growth and development opportunities in China's scientific instrument industry, driven by domestic policy support and the need for self-reliance in technology due to international export restrictions and tariffs [3][13][14]. Group 1: Industry Overview - Scientific instruments are essential for scientific research and analysis, with applications across various sectors including food, pharmaceuticals, agriculture, and environmental monitoring. The life sciences sector accounts for 41% of the analytical instrument market demand [4][10]. - The market for experimental analysis instruments and electronic measurement instruments in China reached approximately 38 billion and 37.8 billion yuan respectively in 2023, together representing over 70% of the scientific instrument market [7]. Group 2: Market Dynamics - The Chinese scientific instrument market is heavily reliant on imports, with over 70% of high-end instruments being imported. However, recent policies and capital support have led to significant progress in domestic alternatives [19]. - The market for mass spectrometers, chromatography, and electronic measurement instruments is expected to grow, with domestic companies increasing their market share from 5% in 2020 to approximately 15% in 2024 [17]. Group 3: Policy and Support - The Chinese government has introduced multiple policies to support the development of scientific instruments, including funding for high-end instruments and prioritizing equipment updates in educational institutions [13][14]. - In 2024, a 20% price subsidy will be provided for domestic products participating in competitive bidding, further encouraging local production [13]. Group 4: Investment Trends - Investment activity in the scientific instrument sector has increased, with numerous funding events occurring since 2025, particularly in early-stage rounds. This reflects a growing interest from capital in the sector's long-term potential [19][20]. - Key areas of investment include mass spectrometers, chromatography, and electronic measurement instruments, with a notable overlap with the pharmaceutical and health sectors [20]. Group 5: Competitive Landscape - The market for mass spectrometers is highly concentrated, with a CR5 of 88%. In Q1 2025, China's mass spectrometer imports amounted to $301 million, while exports were only $57 million, indicating a significant trade imbalance [16][17]. - Domestic products are generally priced at 60% of their foreign counterparts, but performance gaps remain, particularly in high-end instruments [17][18]. Group 6: Future Outlook - The domestic scientific instrument industry is expected to see a substantial increase in the localization rate, driven by technological advancements and supportive policies, positioning it for significant growth in the coming years [18][19].

证券代码：430476 证券简称：海能技术 公告编号：2025-062 海能未来技术集团股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、投资者关系活动类别 □特定对象调研 □其他 二、投资者关系活动情况 活动时间：2025 年 5 月 19 日 活动地点：海能未来技术集团股份有限公司（以下简称"公司"）通过中证 网"中证路演中心"（https://www.cs.com.cn/roadshow/yjsmh/）召开了 2024 年年度报告暨 2025 年第一季度报告说明会。 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 参会单位及人员：通过网络方式参加公司 2024 年年度报告暨 2025 年第一季 度报告说明会的投资者。 上市公司接待人员：公司董事长张振方先生；公司董事、总经理徐渊先生； 公司董事会秘书宋晓东先生；公司财务负责人崔国强先生；公司保荐代表人马婧 瑶女士。 三、投资者关系活动主要内容 本次说明会通过视频对公司情况及2024 ...

Core Viewpoint - The company, Haineng Technology, is experiencing a significant decline in revenue and net profit in 2024, marking the first year of revenue drop in over a decade, but there are signs of recovery in demand and potential growth in 2025 [2][3]. Financial Performance - In 2024, the company reported revenue of approximately 310 million yuan, a decrease of 9.06% year-on-year, and a net profit of 13.07 million yuan, down 70.99% year-on-year [2]. - The first quarter of 2024 saw revenue of 55.50 million yuan, an increase of 37.85% year-on-year, while net profit was negative 0.52 million yuan, reflecting a 96.01% year-on-year improvement [3]. Market Demand and Industry Trends - The decline in revenue is attributed to a slowdown in downstream market demand, particularly in soil testing projects and educational institutions affected by delayed loan policies [2][3]. - The scientific instrument industry is recognized as being in a growth phase, with a consensus on the need for domestic product substitution, which is expected to drive demand [4]. Future Outlook - The company anticipates a recovery in revenue growth in 2025, potentially returning to the growth rate seen in 2023 [2][5]. - Factors supporting future performance include government policies promoting equipment upgrades, increased R&D investments, and a focus on expanding market share [3][4]. Product Development - Haineng Technology is accelerating the development of Fourier Transform Near-Infrared Spectrometers, expected to be launched this year, which will enhance the product portfolio and meet domestic industry needs [5].

Core Viewpoint - The 18th China Scientific Instrument Development Annual Conference (ACCSI 2025) was held in Shanghai, where the "2024 Excellent New Products Award" in the scientific instrument industry was presented, recognizing 15 outstanding instruments [1][2]. Group 1: Event Overview - The award ceremony for the "3i Award - 2024 Excellent New Products in the Scientific Instrument Industry" took place during the ACCSI 2025, attended by over 1,700 industry professionals [2][6]. - The "Excellent New Products Award" aims to showcase innovative domestic and international instruments to Chinese users and encourage manufacturers to innovate [6][10]. Group 2: Award Selection Process - A total of 270 domestic and international manufacturers submitted 871 new instrument products for the award [7]. - After a rigorous evaluation process, 157 products were nominated, and ultimately, 15 instruments were awarded the 2024 Excellent New Products Award [7][10]. Group 3: Awarded Instruments - The awarded instruments include: - Agilent Technologies (China) Co., Ltd. - ProteoAnalyzer Parallel Capillary Protein Electrophoresis System - Thermo Fisher Scientific (China) Co., Ltd. - Thermo Scientific Iliad (Scanning) Transmission Electron Microscope - iQuad 2300P Directional Quantitative Microwave Sample-ICP Mass Spectrometer by Allhengsheng Mass Spectrometry (Beijing) Instrument Co., Ltd. - SURFSeq Q Ultra-High Throughput Gene Sequencing Instrument by Shenzhen Zhenmai Biotechnology Co., Ltd. - SE420 Flow Cytometry Sorting Instrument by Shanghai Weiran Technology Co., Ltd. [8][9].

Core Viewpoint - The "3i Award - 2024 Scientific Instrument Industry User Attention Preferred Award" was held, recognizing 30 instruments that garnered significant user attention in the past year [1][2][5]. Group 1: Event Overview - The 18th China Scientific Instrument Development Annual Conference (ACCSI 2025) took place in Shanghai, attracting over 1,700 participants from various sectors including government, academia, and industry [2]. - The award ceremony for the "3i Award" was a highlight of the event, with notable figures presenting the awards to the winners [2][4]. Group 2: Award Significance - The "3i Award" has been awarded for 17 years, aimed at highlighting high-quality instruments that received significant user attention, serving as a reference for procurement decisions [5]. - Since its inception in 2007, the award has recognized over 400 instruments, receiving widespread acclaim from manufacturers and users alike [5]. Group 3: Award Winners - A detailed list of the award-winning instruments includes various categories such as TOC analyzers, rheometers, and gas chromatography-mass spectrometry (GC-MS) systems, showcasing a diverse range of technologies [5][6]. - Notable winners include the Elementar Total Organic Carbon Analyzer and the AVANCE NEO 600 Nuclear Magnetic Resonance Spectrometer, among others [5][6]. Group 4: About the 3i Award - The 3i Award, which stands for Innovative, Interactive, and Integrative, is organized by Instrument Information Network and aims to recognize outstanding contributions in the scientific instrument and testing industry [7]. - The award process is based on principles of fairness and transparency, relying on evaluations from industry experts and a large user base to select innovative products and commendable enterprises [7].

Core Viewpoint - The 3i Award ceremony at the 18th China Scientific Instrument Development Annual Conference (ACCSI 2025) recognized six outstanding scientific instruments for their contributions to the industry, emphasizing innovation, interaction, and integration [1][5]. Group 1: Award Details - The 3i Award, established in 2006, is co-hosted by Instrument Information Network and Woyaocai Network, focusing on recognizing innovative products and outstanding contributions in the scientific instrument and testing industry [5]. - Six instruments were awarded the "2024 Annual Green Instrument Award," showcasing advancements in technology and environmental considerations [1][4]. - The awarded instruments include: - Plasma 3000 by Steel Research and Testing Technology Co., Ltd. - STA 509 Jupiter by Niche Scientific Instruments Trading (Shanghai) Co., Ltd. - QPursue-6khex by Chengdu Qitan Technology Co., Ltd. - CN802 Carbon and Nitrogen Element Analyzer by Italy's VELP. - ACQUITY QDa II Mass Detector by Waters Technology (Shanghai) Co., Ltd. - LC 5190 Low-Pressure Ultra-High-Performance Liquid Chromatograph by Zhejiang Fuli Analytical Instrument Co., Ltd. [4][5]. Group 2: Event Highlights - The event gathered over 1,700 industry professionals, highlighting the importance of collaboration and recognition in the scientific instrument sector [1][3]. - The 3i Award aims to promote positive energy and accelerate the development of the industry by adhering to principles of fairness and transparency in the selection process [5].

Core Viewpoint - The article highlights the awarding of the "2024 Annual Special Contribution Award for R&D in the Scientific Instrument Industry" to Xu Ying, Chairman of Tianjin Sanying Precision Instrument Co., Ltd., recognizing his significant contributions to the development of high-end scientific instruments in China [1][2]. Group 1: Award Overview - The "China Scientific Instrument Industry R&D Special Contribution Award" was established in 2013 to honor individuals who have made outstanding contributions to scientific instrument technology innovation and industrialization [2][38]. - The award is presented annually at the China Scientific Instrument Development Annual Conference, with a maximum of two recipients each year [2][38]. - The 2025 edition marks the 12th year of the award, with Xu Ying being the 13th recipient [2]. Group 2: Xu Ying's Contributions - Xu Ying, who obtained his PhD from the University of Warwick in 1995, has over 20 years of experience in non-destructive testing and has developed a global perspective through his work in renowned international companies [6]. - He returned to China in 2009 with a mission to contribute to national scientific advancements, leading significant projects such as the development of China's first X-ray three-dimensional microscope with a spatial resolution of 500 nanometers, breaking foreign monopolies [6]. - Under his leadership, Tianjin Sanying Precision Instrument Co., Ltd. has transformed scientific research achievements into internationally advanced products, generating over 850 million yuan in output value and holding 10 invention patents [6]. Group 3: Historical Context of Award Recipients - The article provides a brief overview of past award winners, highlighting their contributions to various fields within scientific instrumentation, such as microwave chemistry, atomic spectroscopy, and the development of advanced analytical instruments [8][10][11][15][18][21][30][33][36]. - Each recipient has played a pivotal role in advancing China's capabilities in scientific instrumentation, often overcoming significant technological challenges and contributing to the country's self-sufficiency in high-tech fields [8][10][11][15][18][21][30][33][36]. Group 4: About the 3i Award - The "3i Award" (Innovative, Interactive, Integrative) was established in 2006 to recognize outstanding contributions in the scientific instrument and testing industry, with a focus on innovation and industry development [39][46]. - The award is based on principles of fairness and transparency, relying on evaluations from industry experts and a large user base to select awardees [39].

Core Viewpoint - The company reported a total operating revenue of 547 million yuan for Q1 2025, reflecting a year-on-year growth of 1.38%, while the net profit attributable to shareholders was -21 million yuan, showing a year-on-year increase of 18.77%. Despite the negative profit, this indicates significant progress in cost control and efficiency improvement [1]. Group 1: Financial Performance - The company achieved total operating revenue of 547 million yuan in Q1 2025, with a year-on-year growth of 1.38% [1]. - The net profit attributable to shareholders was -21 million yuan, representing a year-on-year increase of 18.77% [1]. - The revenue structure shows seasonal characteristics, with Q1 typically accounting for about 15% of total annual revenue, leading to potential fluctuations in overall gross margin due to individual contract differences [1]. Group 2: Business Segments and Growth Opportunities - The company operates in various sectors including environmental monitoring, emergency safety, semiconductors, materials, food and drug, and life sciences, with a strong focus on innovative product offerings and solutions [1]. - Traditional environmental and industrial business segments are expected to maintain stable growth, while the laboratory instruments sector is anticipated to accelerate, particularly in emerging areas like carbon monitoring and medical equipment [2]. - The company has established multiple business units focused on different application scenarios in clinical research and early disease diagnosis, which have launched new products and obtained medical device registrations [3]. Group 3: Technological Advancements - The company has optimized its business units and strengthened cost control, leading to significant improvements in human efficiency [3]. - In the field of mass spectrometry, the company has mastered several key technologies and successfully industrialized various high-end mass spectrometers, enhancing its competitiveness in high-level scientific research [3]. - The company is accelerating the research and promotion of advanced mass spectrometry technologies, which will enrich its product line and support future growth in the life sciences instrument market [3][4].